Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15351 - 15375 of 15415 in total

Propiopromazine

Experimental
Vet approved

{4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone

Experimental

PF-04447943

PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational

Bioymifi

Bioymifi is a small molecule that acts as a tumor necrosis factor-related apoptosis-induced ligand (TRAIL) mimetic. Upon binding to the death receptor 5 (DR5) on cancer cells, bioymifi triggers apoptosis, possibly through a caspase-dependent pathway. Bioymifi is currently being investigated as an anti-tumor agent.[A257048,A257053]
Investigational

2-Nitro-4-cresol

Experimental

Benzoctamine

Benzoctamine is a drug with two main uses. It can be used as a sedative which does not depress the respiratory system, but rather stimulates it. It can also be used as an anxiolytic with the same efficacy as chlordiazepoxide for treating anxiety neurosis.
Experimental

IMIDAZOPYRIDAZIN 1

Experimental

ING-1

ING-1 is a high-affinity, human engineered trade mark monoclonal antibody that recognizes a 40 kilodalton epithelial cell adhesion molecule (EpCAM) glycoprotein that is expressed in high levels on most adenocarcinomas. It is an attractive target for immunotherapy.
Investigational

Amitifadine

Investigational

Zanapezil

Zanapezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.
Investigational

(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine

Experimental

[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone

Experimental

Albaconazole

Albaconazole has been used in trials studying the basic science of Onychomycosis.
Investigational

Oxyfedrine

Experimental

R450

R450 is an alpha 1 antagonist that acts to tighten the muscle tone in the bladder. It is being considered for treatment of stress-related urinary incontinence. Phase IIa data for the drug show it reduced the number of incontinent episodes compared to placebo with minimal cardiovascular effects.
Investigational

Methoxyamine

Investigational

[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL

Experimental

Vestipitant

Vestipitant has been investigated for the treatment of Tinnitus.
Investigational

7-Nitroindazole-2-Carboxamidine

Experimental

5-Nitroindazole

Experimental

2-[1-METHYLHEXYL]-4,6-DINITROPHENOL

Experimental

R-348

Investigational

P-Nitrophenol

Experimental

3-(4-nitrophenyl)-1H-pyrazole

Experimental

(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium

Experimental
Displaying drugs 15351 - 15375 of 15415 in total